| Paclitaxel Liposome studied in …STUDIED_INderived16 of 16show fewer |
|---|
| → studied in | NCT07125391Phase 2 · recruiting Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer · 16 trials list this drug (3 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05766800Phase 2 · recruiting Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer · 16 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06102395Phase 3 · recruiting Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC · 16 trials list this drug (3 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03668730Phase 2 · unknown Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma · 16 trials list this drug (3 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02996214Phase 4 · unknown Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU) · 16 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03603756Phase 2 · unknown SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer · 16 trials list this drug (3 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04217096Phase 4 · unknown Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients · 16 trials list this drug (3 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03020329Phase 2 · unknown Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma · 16 trials list this drug (3 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02861690Phase 2 · completed Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma · 16 trials list this drug (3 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01998347Phase 3 · withdrawn Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer · 16 trials list this drug (3 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01994031Phase 4 · unknown Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments · 16 trials list this drug (3 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142790Phase 4 · unknown Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer · 16 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02163291Phase 2 · unknown Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer · 16 trials list this drug (3 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016900Phase 2 · completed PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus · 16 trials list this drug (3 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00881101Phase 1 · unknown Clinical Study of Liposomal Paclitaxel in Chinese Patients · 16 trials list this drug (3 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00606515Phase 4 · completed Pharmacokinetics Study of Liposomal Paclitaxel in Humans · 16 trials list this drug (3 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |